Bioanalytical Services
Global Leader in Biologics-focused Bioanalytical Solutions
Eurofins Pharma Bioanalytical Services, a division of Eurofins BioPharma Services, is a biologics-focused, global leader in bioanalytical solutions providing over 20 years of industry-leading scientific expertise. We specialize in comprehensive PK/TK, ADA, NAb, Biomarker assays and sample analysis for the world’s largest pharmaceutical and biopharmaceutical companies.
Our mission is to extend our clients' capabilities of improving global health by combining scientific knowledge, capacity, regulatory expertise, and flexibility to provide the trusted, relevant information required for the drug approval process.
SERVICES & SOLUTIONS
|
|
|
Immunogenicity >> |
Biomarkers >> |
Pharmacokinetics (PK)
|
This discussion provides an overview of nanoString technology, as an innovative advancement in digital gene expression analysis. The unique features of this technology include enzyme-free digital gene expression analysis, a dual probe hybridization process, and digital analysis to provide accurate and quantitative measurement of RNA levels. This technology offers advantages over more common methods like qPCR and RNAseq, which will be detailed in the presentation. After imparting an understanding of the capabilities and advantages of the platform, the focus shifts to address many of the criteria and challenges considered in the process of its adoption by our laboratory. Subsequently, the narrative delves into how our laboratory is actively addressing these challenges to maximize the benefits of utilizing this technology to satisfy our clients' clinical testing needs and help advance their biopharmaceutical research.
Click here to access this presentation to explore how using the nanoString nCounter can help measure how different immunotherapy drugs work.
Regulated digital polymerase chain reaction (dPCR), quantitative polymerase chain reaction (qPCR), and reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) are extensively utilized to support biodistribution, vector shedding, gene expression, chimeric antigen receptor (CAR) T cell therapy and oncolytic viral bioanalytical studies.
In this presentation, the featured speakers will review the advantages and disadvantages of dPCR, qPCR, and RT-qPCR as it relates to vaccine and biotherapeutic research. The featured speakers will also discuss the current method development and method validation best practices, context of use, and level of regulatory compliance required to support bioanalysis in the pre-clinical and clinical settings.
Click here to watch this informative webinar to gain insights into the best use of PCR methods in the pre-clinical and clinical development of vaccines and other biotherapeutics.
Click here to read about our 2023 CRO Leadership Awards